Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Dengue virus (DENV) is the predominant mosquito-borne viral pathogen that infects humans with an estimated 50 to 100 million infections per year worldwide. Over the past 50 years, the incidence of dengue disease has increased dramatically and the virus is now endemic in more than 100 countries. More...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Byrd, Chelsea M., Grosenbach, Douglas W., Berhanu, Aklile, Dai, Dongcheng, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Yang, Guang, Tyavanagimatt, Shanthakumar, Harver, Chris, Wineinger, Kristin A., Page, Jessica, Stavale, Eric, Stone, Melialani A., Fuller, Kathleen P., Lovejoy, Candace, Leeds, Janet M., Hruby, Dennis E., Jordan, Robert
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2013
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623359/
https://ncbi.nlm.nih.gov/pubmed/23403421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02251-12
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items